Wednesday 14 October 2026
Export OSCR’s income statement to Excel — free account
Oscar Health, Inc.
OSCR Healthcare Healthcare Plans
Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024. In the quarter to June 2026, revenue grew 70.4%, EPS grew 234.8%, free cash flow grew 316.3% and total debt rose 43.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
33.79
0.22
−0.65%
Follow OSCR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 3 | 4 | 6 |
| (22.27%) | (44.38%) | (2.63%) | 34.24% | ||
| (4.77%) | (7.94%) | (0.52%) | 6.25% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
21.61% | 35.87% | 3.53% | (15.35%) | |
Average Days of Receivables |
17.40 | 18.67 | 26.11 | 18.05 | |
Free Cash Flow per Share |
2.84 | 4.03 | 9.39 | 14.49 | |
Free Cash Flow |
735.64 | 1,058.48 | 2,799.15 | 4,379.95 | |
Capital Expenditures |
(34.13) | (36.37) | (36.14) | (38.62) | |
| Other line items | |||||
Cash ROIC |
19.05% | 25.29% | 40.55% | 66.74% | |
Accounts Receivable Turnover |
25.02 | 23.90 | 17.42 | 23.38 | |
Accounts Payable Turnover |
2.79 | 2.48 | 1.99 | 1.84 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
150.40 | 171.09 | 231.45 | 254.32 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.02 | 0.01 | 0.47 | (0.07) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
17.76% | 17.52% | 17.09% | 15.86% | |
Share Based Compensation of Revenue |
0.85% | 0.75% | 0.59% | 0.49% | |
Interest Coverage |
(8.51) | (22.52) | 0.62 | 39.73 | |
Operating CF/Net income |
(3.15) | (2.47) | (71.91) | 8.02 | |
Depreciation/Fixed assets |
0.00 | 0.01 | 0.03 | 0.02 | |
Capex/Depreciation |
(150.35) | (49.89) | (14.85) | (17.29) | |
Revenue per Share |
43.54 | 44.60 | 44.61 | 50.69 | |
Operating CF per Share |
2.97 | 4.17 | 9.51 | 14.62 | |
Capex per Share |
(0.13) | (0.14) | (0.12) | (0.13) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates